FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Diphenhydramine Injection
Status: Currently in Shortage
»Date first posted: 09/14/2018
»Therapeutic Categories: Pediatric; Pulmonary/Allergy

Expand all

Fresenius Kabi USA, LLC (Reverified 09/19/2018)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
50 mg per vial, Single dose, Amber vial (NDC 63323-664-01) Backordered. Next release September 2018. Check wholesalers for inventory. Demand increase for the drug

Mylan Institutional (New 09/14/2018)

Company Contact Information:
800-796-9526

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg / 10mL(NDC 67457-124-10) Available On manual allocation Other

West-Ward Pharmaceuticals (New 09/14/2018)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
50 mg/mL, 1 mL vial (NDC 0641-0376-25) Inventory is currently available. Additional lots are scheduled to be manufactured in the October 2018 timeframe. Product will be made available as it is released. Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English